Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Under the separation plan, SpinCo will have approximately $2.53 billion (2.45 billion euro) of Galapagos' cash reserves.Galapagos NV (NASDAQ:GLPG) has unveiled plans to divide its operations into two entities, aiming to enhance shareholder value and sharpen strategic focus.
Galapagos NV（納斯達克：GLPG）公佈計劃將其業務分爲兩個實體，旨在提升股東價值並加強戰略重點。
One entity, referred to as SpinCo, will prioritize developing innovative medicines through transformational transactions, while the core Galapagos company will focus on its global cell therapy leadership in oncology.
其中一個實體被稱爲SpinCo，將優先開發通過轉型交易創新的藥物，而核心的Galapagos公司將專注於在腫瘤學領域的全球電芯治療領導地位。
Also Read: Major Investor Says Galapagos Is 'Undervalued,' Plans To Push On Company's 'Performance' And 'Strategic Opportunities'
另請閱讀：主要投資者表示Galapagos被低估，計劃推動公司「績效」和「戰略機會」。
Under the separation plan, SpinCo will have approximately $2.53 billion (2.45 billion euro) of Galapagos' cash reserves.
根據分拆計劃，SpinCo將擁有大約$25.3億（24.5億歐元）來自Galapagos的現金儲備。
It will target oncology, immunology and virology through strategic business deals. SpinCo intends to list its shares on Euronext, with Galapagos shareholders receiving proportional shares of SpinCo. The division will require shareholder approval, with completion anticipated by mid-2025.
它將通過戰略業務交易瞄準腫瘤學、免疫學和病毒學。SpinCo計劃在Euronext上市，Galapagos的股東將按比例獲得SpinCo的股份。該分拆需獲得股東批准，預計將在2025年中期完成。
As part of the separation, Galapagos will amend its 2019 global Option, License and Collaboration Agreement (OLCA) with Gilead Sciences Inc (NASDAQ:GILD).
作爲分拆的一部分，Galapagos將修改其與吉利德科學公司（納斯達克：GILD）於2019年簽署的全球選項、許可和合作協議（OLCA）。
The updated terms grant Galapagos full global development and commercialization rights to its pipeline, subject to royalties on certain product sales.
更新的條款賦予Galapagos對其管道的全面全球開發和商業化權益，但需支付某些產品銷售的特許權使用費。
After the split, the OLCA will apply exclusively to SpinCo. Gilead will hold a 25% stake in both companies post-separation and maintain representation on SpinCo's board.
分拆後，OLCA將專門適用於SpinCo。吉利德在分拆後將持有兩家公司25%的股份，並在SpinCo的董事會中保留代表權。
Galapagos CEO Paul Stoffels emphasized the separation's role in accelerating innovation and growth. He highlighted Galapagos' renewed focus on its decentralized cell therapy platform, which has shown promise in treating relapsed/refractory non-Hodgkin lymphoma.
Galapagos首席執行官Paul Stoffels強調了分拆在加速創新和增長方面的作用。他強調了Galapagos對其去中心化電芯治療平台的重新關注，該平台在治療復發/難治性非霍奇金淋巴瘤方面表現出希望。
To align with this vision, Galapagos plans to exit its small molecule discovery programs and seek partners for related assets, including the TYK2 inhibitor GLPG3667, currently in Phase 2 trials.
爲了與這個願景保持一致，Galapagos計劃退出小分子發現項目，並尋求相關資產的合作伙伴，包括目前處於二期試驗中的TYK2抑制劑GLPG3667。
The restructuring will result in approximately 300 job reductions across Europe, with significant impacts in Belgium and the closure of its French site.
重組將導致歐洲約300個崗位的減少，特別是在比利時會有顯著影響，同時關閉其法國基地。
Galapagos expects to operate from key hubs in the U.S., Netherlands and Belgium, aiming to streamline operations and reduce annual cash burn to 175-225 million euros.
Galapagos預計將在美國、荷蘭和比利時的關鍵中心運營，旨在簡化運營並將年度現金燃燒減少到17500-22500萬歐元。
Galapagos anticipates completing the spin-off by mid-2025.
Galapagos預計將在2025年中期完成分拆。
Price Action: GLPG stock is
價格走勢：GLPG股票是
Read Next:
下一步閱讀：
- eBay Stock Surges After Meta Launches Integration Test For Facebook Marketplace
- eBay股票在Meta推出Facebook市場集成測試後大漲
Photo courtesy of company
圖片由公司提供
譯文內容由第三人軟體翻譯。
